Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Industries BiotechnologyClinical TrialsPharmaceuticalHeadquarters Regions Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) Founded Date Jan 1, 2007 Founders Martin Bonde Operating Status Active Last Funding Type Venture - Series Unknown Also Known As Vaccibody, Nykode Therapeutics Legal Name Nykode Therapeutics AS
Stock Symbol OSE:NYKD Company Type For Profit
Contact Email info@vaccibody.com Phone Number 47 22 95 81 90
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops technology for novel vaccines and immunotherapy against HPV-induced malignancies.